Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 916-461-4 | CAS number: -
Endpoint summary
Administrative data
Description of key information
Acute oral toxicity
LD50 > 2000 mg/kg bw/day (based on assessment)
Acute dermal toxicity
LD50 > 2000 mg/kg bw (based on assessment)
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Additional information
Only short abstracts on the acute oral and dermal toxicity are available for the test item and no information on the composition of the batches tested and on the procedures used is reported.
The acute oral toxicity studies available show LD50 values of 4500 and > 5000 mg/kg bw/day, respectively. In addition to this, data obtained form the repeated dose toxicity study via oral route was considered. The NOAEL found under test conditions was > 1000 mg/kg bw/day.
Two in vivo dermal toxicity studies were carried out on the test substance. The LD50 calculated in the two studies are respectively 1000 and greater than 5000 mg/kg bw/day. One of the two studies (LD50: 1000 mg/kg bw/day) was however disregarded due to inconsistencies with the results of the corrispondent study via oral route (details in the assessment on dermal toxicity).
Justification for classification or non-classification
According to the CLP Regulation (EC 1272/2008), 3.1 Acute toxicity section, substances can be allocated to one of four toxicity categories based on acute toxicity by oral, dermal or inhalation route according to the numeric criteria. Acute toxicity values are expressed as (approximate) LD50 (oral, dermal) or LC50 (inhalation) values or as acute toxicity estimates (ATE).
The oral LD50 value was established to be greater than 2000 mg/kg body weight, upon assessment, therefore test substance is out of the classification limit for acute oral toxicity (oral acute toxicity category 4: 300 < ATE ≤ 2000 mg/kg bw).
The dermal LD50 value was established to be greater than 2000 mg/kg body weight, upon assessment, therefore the test substance is out of the classification limit for acute dermal toxicity (dermal acute toxicity category 4: 1000 < ATE ≤ 2000 mg/kg bw).
Inhalation exposure is unlikely, thus no acute toxicity value is available and no further investigation is required.
In conclusion, test substance does non meet the criteria to be classified for either oral and dermal acute toxicity, according to the CLP Regulation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
